Medipixel

02/12/2025

Medipixel is proud to announce that our MPFFR — an AI-based, angiography-derived FFR measurement technology — has been officially certified as a New Excellent Technology (NET) by the Ministry of Health and Welfare, recognizing it as a first-of-its-kind innovation developed in Korea. 🏆

The NET (New Excellent Technology) Certification is Korea’s national program that validates newly developed health technologies created by domestic companies, universities, and research institutions. The certification recognizes technological excellence, reliability, and commercialization readiness — supporting early market entry and broader industry adoption.

For Medipixel, this certification affirms the technological leadership behind MPFFR, reinforcing its reliability and its potential to bring functional assessment into routine clinical workflow through intuitive and explainable AI.

Above all, this achievement brings us one step closer to our mission:
AI in every case. Smarter decisions for every patient.

01/12/2025

01/12/2025

🚀 Deepening our understanding of the US MedTech landscape!

We were thrilled to host a special lecture by Kenneth KH Huh, PhD this past Wednesday, November 26, 2025, at Medipixel. Dr. Huh delivered a compelling, one-hour-plus session on "Understanding Your Customers: Winning the Minds of Hospital Decision-Makers and MedTech Partners (US Case Study)."

Dr. Huh shared invaluable, real-world insights drawn from his extensive experience at top-tier companies like Samsung Electronics and Philips, bringing the complexities of the US healthcare market to life.

The lecture successfully highlighted the crucial need for focus and diversification when dealing with stakeholders across the entire product lifecycle—from development to business and sales. He made it incredibly easy and engaging to grasp the varying perspectives of internal leaders (CEO, Division Heads, Developers) and external parties (End-Users, Buyers/Purchasers, and ultimately, Patients).

His ability to weave personal anecdotes into strategic business lessons provided a clear roadmap for how to truly win the minds of key decision-makers in the hospital setting.

A huge thank you to Kenneth KH Huh, PhD for sharing his expertise and inspiring our team! 🙏

10/02/2025

메디픽셀의 MP뉴로(MPNeuro)가 식약처 인증을 받았습니다.

MP뉴로는 뇌혈관 조영술 영상을 기반으로 3차원 정량 분석과 코일 형상 분석이 가능한 인공지능(AI) 기반 소프트웨어입니다.

MP뉴로의 행보, 많은 기대 부탁드립니다.

메디픽셀이 뇌혈관 영상 분석 소프트웨어 'MP뉴로(MPNeuro)'의 식품의약품안전처(식약처) 의료기기 인증을 받았다. 회사는 이를 계기로 심혈관 분석을 넘어 뇌혈관 영역까지 확장하며 의료 기술 혁신을 가속화할 전망이다.메디픽.....

06/01/2025

📢 Join us at FRIENDS Live 2025!

Medipixel invites you to the Luncheon Seminar on "Transformation to AI in Interventional Cardiology", hosted as part of the 35th Japanese Society of Cardiovascular Imaging & Dynamics and FRIENDS Live 2025.

🗓️ Date: 18th January 2025
📍 Location: Room 3, Nagoya Convention Hall & Hybrid Studio

Don't miss the chance to explore how artificial intelligence is revolutionizing interventional cardiology. Join us in this insightful discussion led by leading experts in the field!

03/01/2025

Medipixel 2025 New Year's Ceremony

As we welcome 2025, Medipixel embraced the new year with a meaningful New Year’s Ceremony, bringing our entire team together to set the stage for growth and collaboration.

The event revisited the core values we introduced in 2024, showcased our plans for 2025, and included a shared team lunch to foster stronger connections. During the ceremony, employees participated in a lively activity, enthusiastically affirming our three core values and receiving lottery tickets and rice cakes as symbols of encouragement. Each team also shared their business plans, presenting goals and strategies designed to inspire collective success.

The day concluded with a warm and spirited team lunch, a fitting way to step into the new year united in purpose.

We hope 2025 brings even greater success and happiness for everyone. Medipixel remains committed to building a brighter future together.

26/12/2024

🎄 Season’s Greetings from Medipixel 🎄

As 2024 comes to an end, we express our heartfelt gratitude to our team, partners, and supporters for making this year extraordinary. Your constant support fuels our passion for innovation and drives us to create meaningful change in healthcare.

✨ Medipixel's Key Highlights of 2024 included:
✅ Product Innovation
✅ Global Presence Expansion
✅ Sales Activation
✅ Clinical Trial Publication
✅ Collaborations
✅ Awards & Recognition
✅ Intellectual Property
✅ Community Growth

Thank you to our team and supporters for an incredible 2024. Here’s to an even brighter 2025! 🚀

16/12/2024

Our CEO, Andy Kyoseok Song, has been honored with the 2024 Health and Medical Technology Promotion Merit by the Korean Minister of Health and Welfare.

This prestigious award recognizes our exceptional contributions to the national healthcare industry through groundbreaking research and development in healthcare and technology. Medipixel has consistently delivered innovative AI-driven solutions, improving medical efficiency and advancing patient care globally.

This achievement is thanks to the constant support of the entire Medipixel team, as well as the invaluable contributions of the physicians, investors, and partners who work with us to revolutionize healthcare through cutting-edge technology.

Congratulations and here’s to many more milestones for Medipixel!

13/12/2024

Unveiling MPNeuro at the 2024 KSIN: A Revolutionary Step in Cerebrovascular Intervention

Today marks a significant milestone for Medipixel as we unveiled MPNeuro, our groundbreaking product, for the first time at the 2024 KSIN, celebrating the 30th anniversary of the Korean Society of Neurointerventional Medicine.

MPNeuro is designed to analyze cerebral aneurysms using 3D rotational angiography images. Its key features include 3D modeling, accurate quantitative analysis, and a coil synthesis function, supporting precise and efficient coil procedures. We are also working on innovative features that, while unrevealed, are poised to redefine expectations in the field.

During the luncheon session, the response was beyond what we had imagined—enthusiastic engagement and an active Q&A session filled with encouraging words. There was even hope expressed for Korea to lead globally in this space, competing with foreign companies.

A special thanks goes to Vincent Won , our MPNeuro Product Owner. His vision, clinical expertise, and ability to translate complex medical challenges into actionable solutions have been the driving force behind MPNeuro. Watching him lead the team with determination has been inspiring.

Here’s to the next chapter for MPNeuro and Medipixel! 🚀

13/12/2024

Medipixel has successfully obtained the MDSAP (Medical Device Single Audit Program) certification!

This prestigious certification represents compliance with the rigorous medical device quality management standards of five major regions: the United States, Canada, Brazil, Australia, and Japan.

Obtaining MDSAP certification is a significant challenge, widely regarded as one of the most demanding achievements in the medical device industry. However, this milestone was made possible through the dedication and teamwork of the Medipixel family, the expert guidance of the MDSAP certification staff, and the relentless commitment of our RQT members. Through collective effort and resilience, we reached this milestone within the year, tackling each challenge. This milestone reflects Medipixel's strong commitment to maintaining the highest levels of quality and safety in every aspect of our work.

09/12/2024

AI Integration in Cardiac Procedures at Asan Medical Center

We would like to share the following article regarding the latest clinical breakthrough presented at TCT using Medipixel's AI solution.

At Asan Medical Center in Seoul, Professor Jung-Min Ahn has successfully integrated Artificial Intelligence (AI) into coronary artery interventions, revolutionizing the way procedures are performed in the cath lab. By using AI to analyze angiography images and determine the optimal stent size, the team can now provide faster, more accurate treatment, reducing the potential for human error and enhancing patient safety. The use of AI not only improves the precision of coronary interventions but also helps in making the procedure more cost-effective and efficient.

The groundbreaking outcomes of this study have been published in JACC Cardiovascular Interventions and were presented at the TCT Congress in Washington, D.C.

Link to the article in Korean: https://n.news.naver.com/mnews/hotissue/article/022/0003991903?cid=2001903

27/11/2024

Celebrating Excellence in AI Innovation: Medipixel at the 2nd Artificial Intelligence Reliability Awards!

We are delighted to share that Medipixel has been honored with the Excellence Award at this year’s Artificial Intelligence Reliability Awards.

This annual event, hosted by the Ministry of Science and ICT and organized by TTA, KISDI, and Electronic Newspaper, aims to promote the importance of AI credibility and reliability. Winners were rigorously evaluated by leading experts based on their understanding, application, and market impact of AI technologies.

Our solution, MPXA, embodies Medipixel’s commitment to trustworthy and transformative AI in cardiovascular diagnostics. This recognition inspires us to continue pushing the boundaries of innovation in healthcare.

We extend our gratitude to the organizers and congratulate all the other awardees who are shaping the future of AI!